Advances in implantable cardioverter defibrillator therapy
- PMID:26653411
- DOI: 10.1586/14779072.2016.1131124
Advances in implantable cardioverter defibrillator therapy
Abstract
Since the first implant in 1980, implantable cardioverter defibrillator (ICD) technology has progressed rapidly. Modern ICD's have hundreds of programmable options with the general goal of preventing inappropriate shocks and providing shocks for truly life threatening symptomatic ventricular arrhythmias. New studies on ICD programming have shown the benefits of prolonged detection intervals in reaching this goal. Anti-tachycardia pacing (ATP) therapy has become an important adjunct to defibrillator shocks. Remote monitoring technologies have surfaced which have been shown to identify arrhythmias and problems with the device in an expedient fashion. The subcutaneous ICD offers the advantage of avoiding intravascular leads and their inherent risks. Lastly, the current understanding of the effects of MRI in ICD patients has advanced creating new opportunities to provide MRI safely to such patients.
Keywords: ATP; ICD; ICD programming; MRI and ICD; subcutaneous ICD.
Similar articles
- Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.Roses-Noguer F, Jarman JW, Clague JR, Till J.Roses-Noguer F, et al.Heart Rhythm. 2014 Jan;11(1):58-66. doi: 10.1016/j.hrthm.2013.10.027. Epub 2013 Oct 11.Heart Rhythm. 2014.PMID:24120999
- Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).Ruwald AC, Schuger C, Moss AJ, Kutyifa V, Olshansky B, Greenberg H, Cannom DS, Estes NA, Ruwald MH, Huang DT, Klein H, McNitt S, Beck CA, Goldstein R, Brown MW, Kautzner J, Shoda M, Wilber D, Zareba W, Daubert JP.Ruwald AC, et al.Circ Arrhythm Electrophysiol. 2014 Oct;7(5):785-92. doi: 10.1161/CIRCEP.114.001623. Epub 2014 Aug 18.Circ Arrhythm Electrophysiol. 2014.PMID:25136077Clinical Trial.
- Results of ENHANCED Implantable Cardioverter Defibrillator Programming to Reduce Therapies and Improve Quality of Life (from the ENHANCED-ICD Study).Mastenbroek MH, Pedersen SS, van der Tweel I, Doevendans PA, Meine M.Mastenbroek MH, et al.Am J Cardiol. 2016 Feb 15;117(4):596-604. doi: 10.1016/j.amjcard.2015.11.052. Epub 2015 Dec 7.Am J Cardiol. 2016.PMID:26732419Clinical Trial.
- Causes and Prevention of Inappropriate Implantable Cardioverter-Defibrillator Shocks.Kulkarni N, Link MS.Kulkarni N, et al.Card Electrophysiol Clin. 2018 Mar;10(1):67-74. doi: 10.1016/j.ccep.2017.11.006. Epub 2017 Dec 11.Card Electrophysiol Clin. 2018.PMID:29428143Review.
- Expanding the benefits of implantable cardioverter-defibrillator therapy: "is less more"?Jackson LR 2nd, Daubert JP, Thomas KL.Jackson LR 2nd, et al.Prog Cardiovasc Dis. 2012 Jan-Feb;54(4):372-8. doi: 10.1016/j.pcad.2011.11.002.Prog Cardiovasc Dis. 2012.PMID:22226007Review.
Cited by
- "Real life" longevity of implantable cardioverter-defibrillator devices.Manolis AS, Maounis T, Koulouris S, Vassilikos V.Manolis AS, et al.Clin Cardiol. 2017 Sep;40(9):759-764. doi: 10.1002/clc.22729. Epub 2017 May 22.Clin Cardiol. 2017.PMID:28543134Free PMC article.
- Cardiac optogenetics: a decade of enlightenment.Entcheva E, Kay MW.Entcheva E, et al.Nat Rev Cardiol. 2021 May;18(5):349-367. doi: 10.1038/s41569-020-00478-0. Epub 2020 Dec 18.Nat Rev Cardiol. 2021.PMID:33340010Free PMC article.Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical